Advance Nanotech (avna.ob) - 500 Beiträge pro Seite

[BrauchGeld]

Hi

Dieses Unternehmen ist völlig unbekannt aktie läuft erst seit 3 mon.unter diesen namen nachdem sie übernommen worden sind.
Ist auch seit einigen tagen in Berlin handelbar aber noch ist kein umsatz da.
Aktueller kurs ist 0,11€.
Ich bin noch nicht investiert ich weiss leider noch nicht sehr viel über dieses unternehmen .

ADVANCE NANOTECH ist in drei Bereichen tätig: Elektronik, Biopharmazie und Materialien. Neuer CEO ist jetzt Magnus Gittins und CFO Linden Boyne.
Dieses Unternehmen besitzt 17 Firmen,6 im bereich Elektronik,6 in Biopharmazie und 5 in Materialien.

Elektronik Firmen:
http://www.advancenanotech.com/electronics.htm

Biopharma:
http://www.advancenanotech.com/biopharam.htm

Materialien:
http://www.advancenanotech.com/materials.htm

Website:
http://www.advancenanotech.com

Nano-Röhren für billigere Flachbild-TVs
FEDs als Bastard von LCD und Röhrenmonitor | Millionen Mini-Röhren beleuchten Diamantenstaub-Beschichtung | FEDs billiger als andere Technologien bei besserer Bildqualität

Mehrere Unternehmen arbeiten derzeit daran, noch günstigere und leistungsfähigere Flachbildfernseher zu bauen.

Dabei setzen sie nicht auf herkömmliche LCD- oder Plasmavarianten, sondern auf eine relativ junge Technologie, genannt "FED" [field effect display].

FEDs verbrauchen weniger Energie als LCD- oder Plasmaschirme, weisen eine höhere Bildqualität auf und kosten dabei sogar weniger. Basis sind eine spezielle Kohlenstoffbeschichtung und eine hauchdünnes Vakuumfeld.

"Diese Nanoröhren-TVs bieten eine Bildqualität, wie sie sonst nur von herkömmlichen Röhrenbildschirmen erreicht wird", so Tom Pitstick, Marketingchef bei Carbon Nanotechnologies. "Alle großen Hersteller richten derzeit ihre Blicke auf diese Technologie".

Prototyp von Samsung
Der Unterhaltungselektronik-Riese Samsung hat bereits einen Prototypen vorgestellt und rechnet damit, erste Geräte im Jahr 2006 anzubieten. Ein anderes Unternehmen, Advance Nanotech, arbeitet mit der University of Bristol zusammen, um in 18 Monaten ein funktionsfähiges Gerät zu präsentieren.







Letzte News:
Advance Nanotech Enters into Strategic Partnership with the new Centre for Advanced Photonics and Electronics at the University of Cambridge
Thursday March 3, 8:47 am ET


NEW YORK, March 3, 2005 (PRIMEZONE) -- Advance Nanotech, Inc. (OTC BB:AVNA.OB - News), a Company specializing in the acquisition and commercialization of nanotechnology, has today joined global businesses: ALPS Electric Company Limited, Dow Corning Corporation and Marconi Corporation plc, to jointly fund a portfolio of strategic research and development work in electrical engineering at the University of Cambridge.
ADVERTISEMENT


The new Centre for Advanced Photonics and Electronics (CAPE) will unite Advance Nanotech Inc., Alps Electric Company Limited, Dow Corning Corporation and Marconi Corporation plc with leading researchers in the Electrical Engineering Division of the Department of Engineering at the University of Cambridge. CAPE will house the Electrical Division of the engineering department, comprising over 22 academics, 70 post-doctoral researchers and over 170 researchers. Members of the Division publish more than 100 papers each year and in the recent past approximately 70 patents have been filed and 10 spin-out companies have been formed.

Professor Bill Milne will lead this unique consortium, which will address the supply chain in electronics and enable effective transfer of knowledge. Substantial grants from the Higher Education Funding Council for England (HEFCE) through its Science Research Investment Fund (SRIF) are supporting the construction of a purpose-built CAPE building on the University`s growing science and technology campus at West Cambridge. Construction of the new building is underway and scheduled for completion in early 2006. Professor Milne commented, ``We welcome Advance Nanotech as a Strategic Partner to CAPE. Advance Nanotech provides us with additional and innovative commercialization opportunities for the technologies that we develop, with a particular emphasis on nanotechnology.``

Commenting on the agreement, Magnus Gittins, Chief Executive Officer of Advance Nanotech said: ``We are very pleased to be working as a Strategic Partner alongside the University of Cambridge and CAPE`s existing business Partners. The CAPE structure will allow for the cost-effective development of multiple new technologies. Alongside ALPS, Dow Corning and Marconi, we look forward to ensuring the successful commercialization of many of these pioneering efforts.``

About Advance Nanotech Inc

Advance Nanotech, Inc. (``Advance``) commercializes innovative nanotechnologies. Operating in three areas, electronics, biopharma and materials, Advance leverages relationships with financial and development resources to enable a product-focused fast-track commercialization of nanotechnology. Advance has established relationships with academic institutions throughout the world that are at the forefront of nanotechnology research and development. Advance`s objective is to invest in patented innovation to bridge early stage product development with valuable markets.

------------

Advance Nanotech and Toumaz Technology Undertake Joint Venture to Produce the Next Generation of Medical Devices
Wednesday February 16, 1:24 pm ET


NEW YORK, Feb. 16, 2005 (PRIMEZONE) -- Advance Nanotech, Inc., (OTC BB:AVNA.OB - News) has announced a joint venture with Toumaz Technology Ltd. to bridge the gap between nanosystems and the macroscopic world.
ADVERTISEMENT


Bio-Nano Sensium Technologies, the name of the joint venture, will utilize an intelligent, ultra-low power sensor interface, incorporating wireless communication, to create bio-nano sensors that can be implanted within the body to diagnose and treat a wide variety of medical conditions. The development effort will focus on the information and communication technology systems necessary for these sensors to interact with their surrounding environment.

Development of the sensor will leverage the many years of research in ultra-low power circuits and systems at Imperial College of Science, Technology and Medicine, London now exploited by Toumaz Technology Ltd, in their proprietary Advanced Mixed Signal ``AMx`` technology and wireless transceiver devices. The Bio-Nano Sensium will be capable of power consumption orders of a magnitude lower than current state-of-the-art microprocessors. This nano-power mode of operation is vital to the longer lifetimes, reliability, and stability required in biosensors, especially those that are implanted within the body. The Bio-Nano Sensium will be based on industry-standard Complementary Metal Oxide Semiconductor (CMOS) technology so that not only will it have superior functional features to other devices but also be capable of low-cost production.

Keith Errey, CEO of Toumaz Technologies stated, ``We are very excited about this joint venture. Toumaz has worked over the past 4 years in developing a patented, low-power platform technology and we are very pleased to be working with Advance Nanotech to commercialize its use for the next generation of medical devices in the high-value bio-nano sector.``

Commenting on the joint venture, Magnus Gittins, CEO of Advance Nanotech, Inc., said, ``The Bio-Nano Sensium will play a pivotal role in enabling truly personalized healthcare, where continuous diagnosis can be matched to a treatment program tailored to meet the needs of the individual -- all within a small, implantable medical device. Previous investments made by Toumaz Technology into the platform technologies, which make the Bio-Nano Sensium possible, take us well into the commercialization process.``

About Toumaz Technology Ltd.

Toumaz Technology Limited is a developer of advanced RF, analogue and mixed signal semiconductors. The focus of the business is low power devices based on the company`s proprietary AMx(tm) (Advanced Mixed Signal) technology which addresses the needs of lower power consumption for mobile and wirelessly connected systems.

About Advance Nanotech Inc

Advance Nanotech, Inc. (``Advance``) commercializes innovative nanotechnology. Operating in three areas, electronics, biopharma and materials, Advance leverages relationships with financial and development resources to enable a product focused fast-track commercialization of nanotechnology. Advance has established relationships with academic institutions throughout the world that are at the forefront of nanotechnology research and development. Advance`s objective is to invest in patented innovation to bridge early stage product development with valuable markets.

-----------------

Ich hoffe hier sind ein paar Leute dabei die mir helfen mehr über dieses Unternehmen herraus zufinden.

Gute Nacht
B.M.

[Wolframit]

Hast Du mal ne WKN?Merci

[BrauchGeld]

Also bei mir läuft die aktie unter Wkn:A0DP2L in berlin.

[dme3]

Hallo!

Achtung, ich glaube hier werden zwei Unternehmen verwechselt.
Die hier angegebene WKN gehört zu dem Unternehmen : http://www.advancednanotechnology.com/ oder irre ich mich ?

Grüße

dme

[BrauchGeld]

@dme3

Vielleicht hast Du was falsches eingegeben .
Wkn:A0DP2L -- 4 buchstaben und 2 zahlen kombi.

http://de.finance.yahoo.com/q?d=v1&s=a0dp2l&m=a

Gruss
B.M.

[BrauchGeld]

@dme3

Du hast recht es handelt sich um eine andere Firma .Advance ist nur an der otc gelistet.
Sorry hab da wohl nicht richtig hingeguckt.

[dme3]

Hallo BrauchGeld (wer nicht),

ich war mir auch nicht ganz sicher. Klingen ja sehr ähnlich!

dme

[Menglovator]

Mehr dazu auch hier : http://nano.ivcon.org/index.php